Interleukin-6 as diagnostic marker for neonatal sepsis:: Determination of Access® IL-6 cutoff for newborns

被引:0
作者
Prinsen, Jan-Hendrik [1 ]
Baranski, Ellen [2 ]
Posch, Hella [3 ]
Tober, Kerstin [4 ]
Gerstmeyer, Axel [4 ]
机构
[1] Zent Lab, Krankenhaus Bethanien, D-47441 Moers, Germany
[2] Rhon Klin Uelzen & Bad Bevensen, Bad Bevensen, Germany
[3] Ruppiner Klin, Zent Labor, Neuruppin, Germany
[4] Asklepios Klinikum Uckermark, Zentrallabor, Schwedt Oder, Germany
关键词
interleukin-6; C-reactive protein; neonatal septicaemia;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Neonatal infections are by far the most common cause of childhood morbidity and mortality. To accelerate the diagnosis of vi bacterial infection, IL-6 is increasingly used in neonatal diagnostics. The advantage is the level of IL-6 rises at the onset of infection while CRP reaches the maximum concentration with a noticeable delay. This analytical study was conducted to determine the Access IL-6 immunoassay normal range in neonates on postnatal day 1.A, total of 124 serum samples from newborns were collected for IL-6 determination. Only those values were accepted for normal range calculation when the children's leukocyte count and CRP were not elevated and the newborns did not receive any antibiotic medication. The median was determined as 19.5 (SD=14.7). The minimal and maximal IL-6 value was measured as 0.10 and 113 pg/mL, respectively. The upper value of the 95% reference interval was calculated as 44.4 pg/mL with a 90% confidence interval from 30.3 to 66.4 pg/mL. The cutoff determined can now be used to measure IL-6 as a prematurely pro-inflammatory marker in neonates.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 24 条
[1]  
*ARB WISS MED FACH, LEITL GES NEON PAD I
[2]   IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants [J].
Baier, R. John ;
Loggins, John ;
Yanamandra, Krishna .
BMC MEDICINE, 2006, 4 (1)
[3]   Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis [J].
Berner, R ;
Niemeyer, CM ;
Leititis, JU ;
Funke, A ;
Schwab, C ;
Rau, U ;
Richter, K ;
Tawfeek, MSK ;
Clad, A ;
Brandis, M .
PEDIATRIC RESEARCH, 1998, 44 (04) :469-477
[4]  
BOWCOCK A M, 1988, Genomics, V3, P8, DOI 10.1016/0888-7543(88)90152-8
[5]   INTERLEUKIN-6 IS THE MAJOR REGULATOR OF ACUTE PHASE PROTEIN-SYNTHESIS IN ADULT HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
ANDUS, T ;
GEIGER, T ;
TRULLENQUE, R ;
FABRA, R ;
HEINRICH, PC .
FEBS LETTERS, 1989, 242 (02) :237-239
[6]  
COULTER B, TECHNICAL B IL, V6
[7]   Early diagnostic markers for neonatal sepsis: Comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules [J].
Dollner, H ;
Vatten, L ;
Austgulen, R .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (12) :1251-1257
[8]   Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile [J].
Gonzalez, BE ;
Mercado, CK ;
Johnson, L ;
Brodsky, NL ;
Bhandari, V .
JOURNAL OF PERINATAL MEDICINE, 2003, 31 (01) :60-68
[9]   Rapid simultaneous measurement of multiple cytokines using 100 μl sample volumes -: association with neonatal sepsis [J].
Hodge, G ;
Hodge, S ;
Haslam, R ;
McPhee, A ;
Sepulveda, H ;
Morgan, E ;
Nicholson, I ;
Zola, H .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (02) :402-407
[10]   How the immune system works to protect the host from infection: A personal view [J].
Janeway, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) :7461-7468